Yousaf Rimsha, Khan Muhammad Imran, Akhtar Muhammad Furqan, Madni Asadullah, Sohail Muhammad Farhan, Saleem Ammara, Irshad Kanwal, Sharif Ali, Rana Maria
Riphah Institute of Pharmaceutical Sciences, Riphah International University, Lahore Campus, 54000, Lahore, Pakistan.
Department of Pharmaceutics, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, 63100, Pakistan.
Heliyon. 2023 Mar 9;9(3):e14281. doi: 10.1016/j.heliyon.2023.e14281. eCollection 2023 Mar.
Itraconazole (ICZ) is a broad spectrum antifungal drug, but used as second or third line therapy due to its low and erratic oral bioavailability. This work was carried out to prepare and characterize matrix type lipid-polymer hybrid nanoparticles (LPHNPs) for dissolution enhancement of ICZ. LPHNPs were prepared using solvent diffusion/emulsification technique. Matrix LPHNPs were composed of chitosan (polymer), glyceryl monostearate (lipid) and poloxamer 188 (stabilizer). LPHNPs loaded with ICZ (LPHNPs-1, LPHNPs-2, LPHNPs-3 and LPHNPs-4) were developed using varying concentration of chitosan whereas LPHNPs (LPHNPs-5, LPHNPs-6, LPHNPs-7 and LPHNPs-8) were prepared using varying concentrations of poloxamer 188. LPHNPs loaded with ICZ were further evaluated for entrapment efficiency, particle size, polydispersity index (PDI), zeta potential and dissolution profiles at biorelevant pH conditions. The particle size (LPHNPs-1 to LPHNPs-4) was found to be in range of 421-588 nm with PDI values 0.34-0.41. The particles size of LPHNPs-5 to LPHNPs-8 was found to be in range of 489-725 nm with PDI 0.34-0.74. The entrapment efficiency of LPHNPs-1 to LPHNPs-4 was found to be in range of 85.21%-91.34%. The entrapment efficiency of LPHNPs-5 to LPHNPs-8 was found to be in range 78.32%-90.44%. . The scanning electron microscopy of optimized formulations LPHNPs-1 and LPHNPs-5 indicated formation of oval shaped nanoparticles. DSC thermogram of ICZ loaded LPHNPs also depicted the conversion of crystalline form of ICZ into amorphous form demonstrating the internalization and dissolution enhancement of drug in the hybrid matrix. The cumulative drug dissolved at acidic pH 1.2 was found to be 23.3% and 19.8% for LPHNPs-1 and LPHNPs-5 respectively. Similarly at basic pH values 7.4, cumulative amount of drug dissolved was 90.2% and 83.4% for LPHNPs-1 and LPHNPs-5 respectively. Drug dissolution kinetics exhibited fickian diffusion best described by Korse-meyer Peppas model. The results suggested that chitosan and glyceryl monostearate based matrix LPHNPs could be used as promising approach for dissolution enhancement of ICZ which could further increase its bioavailability.
伊曲康唑(ICZ)是一种广谱抗真菌药物,但由于其口服生物利用度低且不稳定,被用作二线或三线治疗药物。本研究旨在制备并表征用于提高ICZ溶出度的基质型脂质-聚合物杂化纳米粒(LPHNPs)。采用溶剂扩散/乳化技术制备LPHNPs。基质LPHNPs由壳聚糖(聚合物)、单硬脂酸甘油酯(脂质)和泊洛沙姆188(稳定剂)组成。使用不同浓度的壳聚糖制备负载ICZ的LPHNPs(LPHNPs-1、LPHNPs-2、LPHNPs-3和LPHNPs-4),而使用不同浓度的泊洛沙姆188制备LPHNPs(LPHNPs-5、LPHNPs-6、LPHNPs-7和LPHNPs-8)。进一步评估负载ICZ的LPHNPs在生物相关pH条件下的包封率、粒径、多分散指数(PDI)、zeta电位和溶出曲线。发现LPHNPs-1至LPHNPs-4的粒径在421-588nm范围内,PDI值为0.34-0.41。LPHNPs-5至LPHNPs-8的粒径在489-725nm范围内,PDI为0.34-0.74。发现LPHNPs-1至LPHNPs-4的包封率在85.21%-91.34%范围内。LPHNPs-5至LPHNPs-8的包封率在78.32%-90.44%范围内。优化制剂LPHNPs-1和LPHNPs-5的扫描电子显微镜显示形成椭圆形纳米粒。负载ICZ的LPHNPs的DSC热谱图也描绘了ICZ晶型向非晶型的转变,证明了药物在杂化基质中的内化和溶出增强。发现在酸性pH 1.2时,LPHNPs-1和LPHNPs-5的累积药物溶出率分别为23.3%和19.8%。同样,在碱性pH值7.4时,LPHNPs-1和LPHNPs-5的药物累积溶出量分别为90.2%和83.4%。药物溶出动力学表现为符合Korse-meyer Peppas模型的菲克扩散。结果表明,基于壳聚糖和单硬脂酸甘油酯的基质LPHNPs可作为提高ICZ溶出度的有前景的方法,这可进一步提高其生物利用度。